 | • レポートコード：MRC2102QY11531 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の月経前症候群薬市場について種類別（PH-80PMD、エストロゲン、プロゲステロン、その他）、用途別（在宅介護、病院、クリニック）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・月経前症候群薬市場の概要 ・世界の主要地域別月経前症候群薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の月経前症候群薬市場規模2015-2026：種類別（PH-80PMD、エストロゲン、プロゲステロン、その他） ・世界の月経前症候群薬市場規模2015-2026：用途別（在宅介護、病院、クリニック） ・月経前症候群薬の米国市場規模2015-2020 ・月経前症候群薬のヨーロッパ市場規模2015-2020 ・月経前症候群薬の中国市場規模2015-2020 ・月経前症候群薬の日本市場規模2015-2020 ・月経前症候群薬の東南アジア市場規模2015-2020 ・月経前症候群薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・月経前症候群薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・月経前症候群薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Premenstrual Syndrome Medicine Market
The global Premenstrual Syndrome Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Premenstrual Syndrome Medicine Scope and Market Size
The global Premenstrual Syndrome Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Premenstrual Syndrome Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Premenstrual Syndrome Medicine market is segmented into
PH-80PMD
Estrogen
Progesterone
Others
Segment by Application, the Premenstrual Syndrome Medicine market is segmented into
Home Care
Hospital
Clinic
The Premenstrual Syndrome Medicine market is analysed and market size information is provided by regions (countries). Segment by Application, the Premenstrual Syndrome Medicine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Premenstrual Syndrome Medicine Market Share Analysis
Premenstrual Syndrome Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Premenstrual Syndrome Medicine business, the date to enter into the Premenstrual Syndrome Medicine market, Premenstrual Syndrome Medicine product introduction, recent developments, etc.
The major vendors covered:
Asarina Pharma AB
Pherin Pharmaceuticals Inc
1 Premenstrual Syndrome Medicine Market Overview
1.1 Premenstrual Syndrome Medicine Product Scope
1.2 Premenstrual Syndrome Medicine Segment by Type
1.2.1 Global Premenstrual Syndrome Medicine Sales by Type (2020-2026)
1.2.2 PH-80PMD
1.2.3 Estrogen
1.2.4 Progesterone
1.2.5 Others
1.3 Premenstrual Syndrome Medicine Segment by Application
1.3.1 Global Premenstrual Syndrome Medicine Sales Comparison by Application (2020-2026)
1.3.2 Home Care
1.3.3 Hospital
1.3.4 Clinic
1.4 Premenstrual Syndrome Medicine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Premenstrual Syndrome Medicine Sales Growth Rate (2015-2026)
1.4.2 Global Premenstrual Syndrome Medicine Revenue and Growth Rate (2015-2026)
1.4.3 Global Premenstrual Syndrome Medicine Price Trends (2015-2026)
2 Premenstrual Syndrome Medicine Estimate and Forecast by Region
2.1 Global Premenstrual Syndrome Medicine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Premenstrual Syndrome Medicine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Premenstrual Syndrome Medicine Sales Market Share by Region (2015-2020)
2.2.2 Global Premenstrual Syndrome Medicine Revenue Market Share by Region (2015-2020)
2.3 Global Premenstrual Syndrome Medicine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Premenstrual Syndrome Medicine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Premenstrual Syndrome Medicine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Premenstrual Syndrome Medicine Estimates and Projections (2015-2026)
2.4.2 Europe Premenstrual Syndrome Medicine Estimates and Projections (2015-2026)
2.4.3 China Premenstrual Syndrome Medicine Estimates and Projections (2015-2026)
2.4.4 Japan Premenstrual Syndrome Medicine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Premenstrual Syndrome Medicine Estimates and Projections (2015-2026)
2.4.6 India Premenstrual Syndrome Medicine Estimates and Projections (2015-2026)
3 Global Premenstrual Syndrome Medicine Competition Landscape by Players
3.1 Global Top Premenstrual Syndrome Medicine Players by Sales (2015-2020)
3.2 Global Top Premenstrual Syndrome Medicine Players by Revenue (2015-2020)
3.3 Global Premenstrual Syndrome Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premenstrual Syndrome Medicine as of 2019)
3.4 Global Premenstrual Syndrome Medicine Average Price by Company (2015-2020)
3.5 Manufacturers Premenstrual Syndrome Medicine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Premenstrual Syndrome Medicine Players (Opinion Leaders)
4 Global Premenstrual Syndrome Medicine Market Size by Type
4.1 Global Premenstrual Syndrome Medicine Historic Market Review by Type (2015-2020)
4.1.1 Global Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
4.1.2 Global Premenstrual Syndrome Medicine Revenue Market Share by Type (2015-2020)
4.1.3 Global Premenstrual Syndrome Medicine Price by Type (2015-2020)
4.2 Global Premenstrual Syndrome Medicine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Premenstrual Syndrome Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Premenstrual Syndrome Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Global Premenstrual Syndrome Medicine Price Forecast by Type (2021-2026)
5 Global Premenstrual Syndrome Medicine Market Size by Application
5.1 Global Premenstrual Syndrome Medicine Historic Market Review by Application (2015-2020)
5.1.1 Global Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
5.1.2 Global Premenstrual Syndrome Medicine Revenue Market Share by Application (2015-2020)
5.1.3 Global Premenstrual Syndrome Medicine Price by Application (2015-2020)
5.2 Global Premenstrual Syndrome Medicine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Premenstrual Syndrome Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Premenstrual Syndrome Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Premenstrual Syndrome Medicine Price Forecast by Application (2021-2026)
6 United States Premenstrual Syndrome Medicine Market Facts & Figures
6.1 United States Premenstrual Syndrome Medicine Sales Market Share by Company (2015-2020)
6.2 United States Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
6.3 United States Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
7 Europe Premenstrual Syndrome Medicine Market Facts & Figures
7.1 Europe Premenstrual Syndrome Medicine Sales Market Share by Company (2015-2020)
7.2 Europe Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
7.3 Europe Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
8 China Premenstrual Syndrome Medicine Market Facts & Figures
8.1 China Premenstrual Syndrome Medicine Sales Market Share by Company (2015-2020)
8.2 China Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
8.3 China Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
9 Japan Premenstrual Syndrome Medicine Market Facts & Figures
9.1 Japan Premenstrual Syndrome Medicine Sales Market Share by Company (3015-3030)
9.2 Japan Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
9.3 Japan Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
10 Southeast Asia Premenstrual Syndrome Medicine Market Facts & Figures
10.1 Southeast Asia Premenstrual Syndrome Medicine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
11 India Premenstrual Syndrome Medicine Market Facts & Figures
11.1 India Premenstrual Syndrome Medicine Sales Market Share by Company (2015-2020)
11.2 India Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
11.3 India Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Premenstrual Syndrome Medicine Business
12.1 Asarina Pharma AB
12.1.1 Asarina Pharma AB Corporation Information
12.1.2 Asarina Pharma AB Business Overview
12.1.3 Asarina Pharma AB Premenstrual Syndrome Medicine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Asarina Pharma AB Premenstrual Syndrome Medicine Products Offered
12.1.5 Asarina Pharma AB Recent Development
12.2 Pherin Pharmaceuticals Inc
12.2.1 Pherin Pharmaceuticals Inc Corporation Information
12.2.2 Pherin Pharmaceuticals Inc Business Overview
12.2.3 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Products Offered
12.2.5 Pherin Pharmaceuticals Inc Recent Development
…
13 Premenstrual Syndrome Medicine Manufacturing Cost Analysis
13.1 Premenstrual Syndrome Medicine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Premenstrual Syndrome Medicine
13.4 Premenstrual Syndrome Medicine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Premenstrual Syndrome Medicine Distributors List
14.3 Premenstrual Syndrome Medicine Customers
15 Market Dynamics
15.1 Premenstrual Syndrome Medicine Market Trends
15.2 Premenstrual Syndrome Medicine Opportunities and Drivers
15.3 Premenstrual Syndrome Medicine Market Challenges
15.4 Premenstrual Syndrome Medicine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Premenstrual Syndrome Medicine Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Premenstrual Syndrome Medicine Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Premenstrual Syndrome Medicine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Premenstrual Syndrome Medicine Sales (K Pcs) by Region (2015-2020)
Table 5. Global Premenstrual Syndrome Medicine Sales Market Share by Region (2015-2020)
Table 6. Global Premenstrual Syndrome Medicine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Premenstrual Syndrome Medicine Revenue Share by Region (2015-2020)
Table 8. Global Premenstrual Syndrome Medicine Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Premenstrual Syndrome Medicine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Premenstrual Syndrome Medicine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Premenstrual Syndrome Medicine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Premenstrual Syndrome Medicine (K Pcs) of Key Companies (2015-2020)
Table 13. Global Premenstrual Syndrome Medicine Sales Share by Company (2015-2020)
Table 14. Global Premenstrual Syndrome Medicine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Premenstrual Syndrome Medicine Revenue Share by Company (2015-2020)
Table 16. Global Premenstrual Syndrome Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premenstrual Syndrome Medicine as of 2019)
Table 17. Global Premenstrual Syndrome Medicine Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Premenstrual Syndrome Medicine Manufacturing Sites and Area Served
Table 19. Manufacturers Premenstrual Syndrome Medicine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Premenstrual Syndrome Medicine Players
Table 22. Global Premenstrual Syndrome Medicine Sales (K Pcs) by Type (2015-2020)
Table 23. Global Premenstrual Syndrome Medicine Sales Share by Type (2015-2020)
Table 24. Global Premenstrual Syndrome Medicine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Premenstrual Syndrome Medicine Price (K Pcs) by Type (2015-2020)
Table 26. Global Premenstrual Syndrome Medicine Sales Share by Type (2021-2026)
Table 27. Global Premenstrual Syndrome Medicine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Premenstrual Syndrome Medicine Revenue Share by Type (2021-2026)
Table 29. Global Premenstrual Syndrome Medicine Price (K Pcs) by Type (2021-2026)
Table 30. Global Premenstrual Syndrome Medicine Sales (K Pcs) by Application (2015-2020)
Table 31. Global Premenstrual Syndrome Medicine Sales Share by Application (2015-2020)
Table 32. Global Premenstrual Syndrome Medicine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Premenstrual Syndrome Medicine Price (K Pcs) by Application (2015-2020)
Table 34. Global Premenstrual Syndrome Medicine Sales (K Pcs) by Application (2021-2026)
Table 35. Global Premenstrual Syndrome Medicine Sales Share by Application (2021-2026)
Table 36. Global Premenstrual Syndrome Medicine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Premenstrual Syndrome Medicine Revenue Share by Application (2021-2026)
Table 38. Global Premenstrual Syndrome Medicine Price (K Pcs) by Application (2021-2026)
Table 39. United States Premenstrual Syndrome Medicine Sales (K Pcs) by Company (2015-2020)
Table 40. United States Premenstrual Syndrome Medicine Sales Market Share by Company (2015-2020)
Table 41. United States Premenstrual Syndrome Medicine Sales (K Pcs) by Type (2015-2020)
Table 42. United States Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
Table 43. United States Premenstrual Syndrome Medicine Sales (K Pcs) by Application (2015-2020)
Table 44. United States Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
Table 45. Europe Premenstrual Syndrome Medicine Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Premenstrual Syndrome Medicine Sales Market Share by Company (2015-2020)
Table 47. Europe Premenstrual Syndrome Medicine Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
Table 49. Europe Premenstrual Syndrome Medicine Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
Table 51. China Premenstrual Syndrome Medicine Sales (K Pcs) by Company (2015-2020)
Table 52. China Premenstrual Syndrome Medicine Sales Market Share by Company (2015-2020)
Table 53. China Premenstrual Syndrome Medicine Sales (K Pcs) by Type (2015-2020)
Table 54. China Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
Table 55. China Premenstrual Syndrome Medicine Sales (K Pcs) by Application (2015-2020)
Table 56. China Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
Table 57. Japan Premenstrual Syndrome Medicine Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Premenstrual Syndrome Medicine Sales Market Share by Company (2015-2020)
Table 59. Japan Premenstrual Syndrome Medicine Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
Table 61. Japan Premenstrual Syndrome Medicine Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Premenstrual Syndrome Medicine Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Premenstrual Syndrome Medicine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Premenstrual Syndrome Medicine Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Premenstrual Syndrome Medicine Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
Table 69. India Premenstrual Syndrome Medicine Sales (K Pcs) by Company (2015-2020)
Table 70. India Premenstrual Syndrome Medicine Sales Market Share by Company (2015-2020)
Table 71. India Premenstrual Syndrome Medicine Sales (K Pcs) by Type (2015-2020)
Table 72. India Premenstrual Syndrome Medicine Sales Market Share by Type (2015-2020)
Table 73. India Premenstrual Syndrome Medicine Sales (K Pcs) by Application (2015-2020)
Table 74. India Premenstrual Syndrome Medicine Sales Market Share by Application (2015-2020)
Table 75. Asarina Pharma AB Corporation Information
Table 76. Asarina Pharma AB Description and Business Overview
Table 77. Asarina Pharma AB Premenstrual Syndrome Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Asarina Pharma AB Premenstrual Syndrome Medicine Product
Table 79. Asarina Pharma AB Recent Development
Table 80. Pherin Pharmaceuticals Inc Corporation Information
Table 81. Pherin Pharmaceuticals Inc Description and Business Overview
Table 82. Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Product
Table 84. Pherin Pharmaceuticals Inc Recent Development
Table 85. Production Base and Market Concentration Rate of Raw Material
Table 86. Key Suppliers of Raw Materials
Table 87. Premenstrual Syndrome Medicine Distributors List
Table 88. Premenstrual Syndrome Medicine Customers List
Table 89. Premenstrual Syndrome Medicine Market Key Trends
Table 90. Premenstrual Syndrome Medicine Key Opportunities and Drivers
Table 91. Premenstrual Syndrome Medicine Market Challenges
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Premenstrual Syndrome Medicine Product Picture
Figure 2. Global Premenstrual Syndrome Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Premenstrual Syndrome Medicine Market Share by Application in 2020 & 2026
Figure 6. Home Care Examples
Figure 7. Hospital Examples
Figure 8. Clinic Examples
Figure 9. Global Premenstrual Syndrome Medicine Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Premenstrual Syndrome Medicine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Premenstrual Syndrome Medicine Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Premenstrual Syndrome Medicine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Premenstrual Syndrome Medicine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Premenstrual Syndrome Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Premenstrual Syndrome Medicine Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Premenstrual Syndrome Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Premenstrual Syndrome Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Premenstrual Syndrome Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Premenstrual Syndrome Medicine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Premenstrual Syndrome Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Premenstrual Syndrome Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Premenstrual Syndrome Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Premenstrual Syndrome Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Premenstrual Syndrome Medicine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Premenstrual Syndrome Medicine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Premenstrual Syndrome Medicine Players Market Share by Revenue in Premenstrual Syndrome Medicine 2015 & 2019
Figure 27. Premenstrual Syndrome Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Premenstrual Syndrome Medicine Revenue Share by Type (2015-2020)
Figure 29. Global Premenstrual Syndrome Medicine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Premenstrual Syndrome Medicine Revenue Share by Application (2015-2020)
Figure 31. Global Premenstrual Syndrome Medicine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Premenstrual Syndrome Medicine Sales Market Share by Type in 2019
Figure 33. United States Premenstrual Syndrome Medicine Sales Market Share by Type in 2019
Figure 34. Europe Premenstrual Syndrome Medicine Sales Market Share by Company in 2019
Figure 35. Europe Premenstrual Syndrome Medicine Sales Market Share by Type in 2019
Figure 36. Europe Premenstrual Syndrome Medicine Sales Market Share by Application in 2019
Figure 37. China Premenstrual Syndrome Medicine Sales Market Share by Company in 2019
Figure 38. China Premenstrual Syndrome Medicine Sales Market Share by Type in 2019
Figure 39. China Premenstrual Syndrome Medicine Sales Market Share by Application in 2019
Figure 40. Japan Premenstrual Syndrome Medicine Sales Market Share by Company in 2019
Figure 41. Japan Premenstrual Syndrome Medicine Sales Market Share by Type in 2019
Figure 42. Japan Premenstrual Syndrome Medicine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Premenstrual Syndrome Medicine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Premenstrual Syndrome Medicine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Premenstrual Syndrome Medicine Sales Market Share by Application in 2019
Figure 46. India Premenstrual Syndrome Medicine Sales Market Share by Company in 2019
Figure 47. India Premenstrual Syndrome Medicine Sales Market Share by Type in 2019
Figure 48. India Premenstrual Syndrome Medicine Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Premenstrual Syndrome Medicine
Figure 51. Manufacturing Process Analysis of Premenstrual Syndrome Medicine
Figure 52. Premenstrual Syndrome Medicine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
過敏性腸症候群（IBS）の世界市場レポート2020 Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predomin…- 下痢同伴過敏性腸症候群（IBS-D）治療薬の世界市場レポート2020 Rifaximin (Xifaxan) is an antibiotic medication for IBS-D that works by reducing or altering gut bacteria, and it can improve symptoms of bloating and diarrhea after a 10 to 14 day course of treatment. Some patients require retreatment at higher doses for symptom relief. Market Analysis and Insights…
- 便秘薬による過敏性腸症候群の世界市場レポート2020 The symptoms of IBS-C include abdominal pain and discomfort, along with changes in bowel function. Bloating and/or gas also may happen. Changes in bowel function may include straining, infrequent stools, hard or lumpy stools, and/or a feeling that the bowel does not empty completely. Market Analysis…
- 豚生殖・呼吸器症候群ワクチンの世界市場レポート2020 Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population. Boehringer ingelheim is the company with the largest market share, about 25 percent. Market Analysis and Insights: Global S…
- 医療用イオントフォレーシス機器の世界市場レポート2020 Medicine Iontophoresis Instrument is based on the theory of bioelectricity medication guide, bionic theory, heat, magnetism, classical Chinese Medicine of traditional Chinese Medicine and modern microcomputer technology, combined with years of clinical practice and a large number of user feedback on…